Dataset Information


Catalytic subunits switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells [ChIP-seq]

ABSTRACT: The SWI/SNF chromatin remodeling complex is altered in ~20% of human cancers. ARID1A, a component of the SWI/SNF chromatin-remodeling complex, is the most frequently mutated epigenetic regulator in human cancers. Inactivation of the SWI/SNF complex is synthetically lethal with inhibition of EZH2 activity. EZH2 inhibitors are entering clinical trials for specific tumor types with SWI/SNF mutations. However, mechanisms of de novo or acquired resistance to EZH2 inhibitors in cancers with inactivating SWI/SNF mutations are unknown. Here we show that the switch of the SWI/SNF catalytic subunits from SMARCA4 to SMARCA2 drives resistance to EZH2 inhibitors in ARID1A-mutated ovarian cancer cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE110448 | GEO | 2019/02/10


Similar Datasets

2019-02-10 | GSE110449 | GEO
2018-03-09 | GSE107201 | GEO
2020-10-21 | MSV000086347 | MassIVE
2023-05-01 | GSE150249 | GEO
2022-03-14 | GSE195503 | GEO
2020-04-14 | PXD017898 | Pride
2017-07-14 | GSE84405 | GEO
2020-12-02 | GSE162525 | GEO
2020-12-02 | GSE162523 | GEO
2020-12-02 | GSE162522 | GEO